Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Icahn School of Medicine at Mount Sinai · Chan Zuckerberg Initiative (United States) · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
4,502
total citations
- FWCI
- 99.51
- Percentile
- 100%
- References
- 60
Citations per year
Authors
15- DBDaniel Blanco-MeloCorresponding
Icahn School of Medicine at Mount Sinai
- BEBenjamin E. Nilsson-Payant
Icahn School of Medicine at Mount Sinai
- WLWen‐Chun Liu
Icahn School of Medicine at Mount Sinai
- SUSkyler Uhl
Icahn School of Medicine at Mount Sinai
- DADaisy A. Hoagland
Icahn School of Medicine at Mount Sinai
Topics & keywords
Topics
Keywords
- Biology
- Chemokine
- Immunology
- Pandemic
- Virology
- Coronavirus disease 2019 (COVID-19)
- Innate immune system
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.